Author

Wencheng Li

PTC Therapeutics (United States)ORCID 0000-0003-1783-2009Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:deep learning· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Amal Dakka· 1 shared Anil K. ChekuriiD· 1 shared Aram J. KrausoniD· 1 shared Ashok RagavendraniD· 1 shared Christopher R. TrottaiD· 1 shared Christos G. GkogkasiD· 1 shared Dadi GaoiD· 1 shared Elisabetta MoriniiD· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Amal Dakka

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsbioRxivPreprintFeb 3, 2020

A deep learning approach to identify new gene targets of a novel therapeutic for human splicing disorders

Dadi Gao, Elisabetta Morini, Monica Salani…·Susan A. Slaugenhaupt

The paper uses deep learning to identify new gene targets for a splicing modulator drug, validating predictions with in vitro assays.

8 citations

humanbulk RNA-seq

𝕏 PostBluesky

Molecular BiologyCell ReportsPeer-reviewedDec 1, 2019

Induction of an alternative 5’ leader enhances translation of Inpp5e and resistance to oncolytic virus infection

Huy‐Dung Hoang, Tyson Ernst Graber, Jianjun Jia…·Tommy Alain

The paper identifies an alternative 5' leader in Inpp5e mRNA that enhances translation and confers resistance to oncolytic virus infection in cancer cells.

18 citations

mousebulk RNA-seq

𝕏 PostBluesky